Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Stanley T Crooke. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Stanley T Crooke har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:IONS / Ionis Pharmaceuticals, Inc. | Exec Chairman of the Board, Director | 2 021 |
Director | 0 | |
US:RGLS / Regulus Therapeutics Inc. | Director, 10% Owner | 25 000 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Stanley T Crooke. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp IONS / Ionis Pharmaceuticals, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i IONS / Ionis Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i IONS / Ionis Pharmaceuticals, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Stanley T Crooke som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-01-28 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −28 333 | 2 021 | −93,34 | 63,74 | −1 805 812 | 128 809 |
2021-01-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −40 000 | 494 391 | −7,49 | 61,68 | −2 467 000 | 30 491 565 |
2021-01-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −21 042 | 534 391 | −3,79 | 61,65 | −1 297 239 | 32 945 205 |
2021-01-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −13 958 | 555 433 | −2,45 | 60,53 | −844 878 | 33 620 359 |
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −4 371 | 7 801 | −35,91 | ||||
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −47 257 | 87 885 | −34,97 | ||||
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 5 333 | 5 333 | |||||
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −1 434 | 3 111 | −31,55 | 61,28 | −87 876 | 190 642 | |
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 371 | 4 545 | 2 512,07 | ||||
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −18 924 | 30 354 | −38,40 | 61,28 | −1 159 663 | 1 860 093 | |
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 47 257 | 49 278 | 2 338,30 | ||||
2021-01-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | |||||
2021-01-06 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
G - Gift | −31 000 | 569 391 | −5,16 | ||||
2020-12-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 407 | 174 | −88,99 | 50,50 | −71 054 | 8 787 |
2020-12-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −39 000 | 600 391 | −6,10 | 49,78 | −1 941 225 | 29 884 462 |
2020-12-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 000 | 639 391 | −0,93 | 51,50 | −309 000 | 32 928 636 |
2020-12-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 645 391 | −0,77 | 51,87 | −259 350 | 33 476 496 |
2020-11-30 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −12 990 | 0 | −100,00 | ||||
2020-11-30 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 990 | 2 021 | −86,54 | 50,05 | −650 150 | 101 151 |
2020-11-30 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 990 | 15 011 | 642,75 | 39,87 | 517 911 | 598 489 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 590 | 12 990 | −16,62 | ||||
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 590 | 2 021 | −56,17 | 50,83 | −131 650 | 102 727 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 590 | 4 611 | 128,15 | 39,87 | 103 263 | 183 841 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −11 600 | 15 580 | −42,68 | ||||
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −500 | 0 | −100,00 | ||||
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 600 | 2 021 | −85,16 | 50,11 | −581 276 | 101 272 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 11 600 | 13 621 | 573,97 | 39,87 | 462 492 | 543 069 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 1 581 | −24,03 | 50,00 | −25 000 | 79 050 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 2 081 | 31,63 | 39,87 | 19 935 | 82 969 |
2020-09-23 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −50 000 | 650 391 | −7,14 | 50,41 | −2 520 460 | 32 785 690 |
2020-09-23 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 1 581 | −55,85 | 50,18 | −100 360 | 79 335 |
2020-06-26 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 914 | 2 021 | −83,07 | 60,11 | −595 907 | 121 477 |
2020-06-26 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 11 935 | −29,52 | 58,80 | −294 000 | 701 778 |
2020-06-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 16 935 | −37,13 | 58,32 | −583 250 | 987 734 |
2020-06-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 3 581 | −35,84 | 58,25 | −116 500 | 208 593 |
2020-06-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 000 | 26 935 | −35,77 | 57,90 | −868 521 | 1 559 574 |
2020-03-27 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 5 581 | −15,20 | 47,00 | −47 000 | 262 307 |
2020-03-27 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 000 | 41 935 | −26,35 | 47,00 | −705 000 | 1 970 945 |
2020-03-27 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −4 349 | 71 935 | −5,70 | 45,00 | −195 705 | 3 237 075 | |
2020-03-27 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −5 651 | 76 284 | −6,90 | 45,00 | −254 295 | 3 432 780 | |
2020-03-27 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −5 421 | 81 935 | −6,21 | 44,50 | −241 234 | 3 646 108 | |
2020-03-27 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −4 579 | 87 356 | −4,98 | 44,50 | −203 766 | 3 887 342 | |
2020-03-23 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 6 581 | −13,19 | 45,00 | −45 000 | 296 145 |
2020-03-23 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 56 545 | −8,12 | 46,00 | −230 000 | 2 601 070 |
2020-03-23 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 61 545 | −13,98 | 44,75 | −447 546 | 2 754 422 |
2020-03-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
COMMON STOCK |
S - Sale | X | −4 349 | 71 545 | −5,73 | 45,00 | −195 705 | 3 219 525 |
2020-03-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
COMMON STOCK |
S - Sale | X | −5 651 | 75 894 | −6,93 | 45,00 | −254 295 | 3 415 230 |
2020-03-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
COMMON STOCK |
S - Sale | X | −5 421 | 81 545 | −6,23 | 44,50 | −241 234 | 3 628 752 |
2020-03-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
COMMON STOCK |
S - Sale | X | −4 969 | 86 966 | −5,40 | 44,50 | −221 120 | 3 869 987 |
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −3 317 | 6 627 | −33,36 | ||||
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −39 643 | 72 160 | −35,46 | ||||
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 5 545 | 5 545 | |||||
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 62 982 | 62 982 | |||||
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −1 268 | 7 581 | −14,33 | 62,06 | −78 692 | 470 477 | |
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 317 | 8 849 | 59,96 | ||||
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −17 342 | 91 935 | −15,87 | 62,06 | −1 076 245 | 5 705 486 | |
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 39 643 | 109 277 | 56,93 | ||||
2020-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 12 477 | 12 477 | |||||
2020-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 141 709 | 141 709 | |||||
2020-01-03 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
G - Gift | −25 000 | 700 391 | −3,45 | ||||
2019-08-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 27 180 | −26,90 | ||||
2019-08-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 69 634 | −12,56 | 72,15 | −721 500 | 5 024 093 |
2019-08-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 79 634 | 14,36 | 39,87 | 398 700 | 3 175 008 |
2019-08-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 000 | 500 | −80,00 | ||||
2019-08-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 37 180 | −21,20 | ||||
2019-08-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 5 532 | −26,55 | 71,00 | −142 000 | 392 772 |
2019-08-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 7 532 | 36,15 | 39,87 | 79 740 | 300 301 |
2019-08-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 69 634 | −12,56 | 71,00 | −710 000 | 4 944 014 |
2019-08-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 79 634 | 14,36 | 39,87 | 398 700 | 3 175 008 |
2019-07-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 47 180 | −17,49 | ||||
2019-07-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 69 634 | −12,56 | 70,25 | −702 506 | 4 891 830 |
2019-07-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 79 634 | 14,36 | 39,87 | 398 700 | 3 175 008 |
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −700 | 2 500 | −21,88 | ||||
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −300 | 0 | −100,00 | ||||
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −13 320 | 57 180 | −18,89 | ||||
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −6 680 | 0 | −100,00 | ||||
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −700 | 5 532 | −11,23 | 84,75 | −59 325 | 468 837 |
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 700 | 6 232 | 12,65 | 39,87 | 27 909 | 248 470 |
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 5 532 | −5,14 | 84,75 | −25 425 | 468 837 |
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 300 | 5 832 | 5,42 | 10,82 | 3 246 | 63 102 |
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −13 320 | 69 634 | −16,06 | 84,56 | −1 126 370 | 5 888 411 |
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 13 320 | 82 954 | 19,13 | 39,87 | 531 068 | 3 307 376 |
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 680 | 69 634 | −8,75 | 84,75 | −566 130 | 5 901 482 |
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 680 | 76 314 | 9,59 | 14,69 | 98 129 | 1 121 053 |
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 300 | −76,92 | ||||
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 6 680 | −59,95 | ||||
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 5 532 | −15,31 | 85,25 | −85 250 | 471 603 |
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 6 532 | 18,08 | 10,82 | 10 820 | 70 676 |
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 69 634 | −12,56 | 85,25 | −852 500 | 5 936 298 |
2019-04-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 79 634 | 14,36 | 14,69 | 146 900 | 1 169 823 |
2019-02-27 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −37 000 | 70 500 | −34,42 | ||||
2019-02-27 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −37 000 | 69 634 | −34,70 | 61,54 | −2 276 799 | 4 284 935 |
2019-02-27 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 37 000 | 106 634 | 53,13 | 39,87 | 1 475 190 | 4 251 498 |
2019-02-27 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −40 000 | 107 500 | −27,12 | ||||
2019-02-27 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −40 000 | 69 634 | −36,49 | 60,07 | −2 402 700 | 4 182 740 |
2019-02-27 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 40 000 | 109 634 | 57,44 | 39,87 | 1 594 800 | 4 371 108 |
2019-02-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 300 | 3 200 | −62,35 | ||||
2019-02-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 604 | 1 300 | −55,23 | ||||
2019-02-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −40 000 | 147 500 | −21,33 | ||||
2019-02-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 300 | 5 532 | −48,93 | 60,00 | −318 000 | 331 920 |
2019-02-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 300 | 10 832 | 95,81 | 39,87 | 211 311 | 431 872 |
2019-02-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 604 | 5 532 | −22,48 | 60,00 | −96 240 | 331 920 |
2019-02-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 604 | 7 136 | 28,99 | 10,82 | 17 355 | 77 212 |
2019-02-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −40 000 | 69 634 | −36,49 | 60,10 | −2 404 028 | 4 185 052 |
2019-02-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 40 000 | 109 634 | 57,44 | 39,87 | 1 594 800 | 4 371 108 |
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −2 346 | 4 612 | −33,72 | ||||
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −30 587 | 48 077 | −38,88 | ||||
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 5 332 | 5 332 | |||||
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 63 726 | 63 726 | |||||
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −942 | 5 532 | −14,55 | 58,26 | −54 881 | 322 294 | |
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 346 | 6 474 | 56,83 | ||||
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −12 686 | 69 634 | −15,41 | 58,26 | −739 086 | 4 056 877 | |
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 30 587 | 82 320 | 59,12 | ||||
2019-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | |||||
2019-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 143 400 | 143 400 | |||||
2018-04-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −4 000 | 2 904 | −57,94 | ||||
2018-04-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −9 962 | 16 680 | −37,39 | ||||
2018-04-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 4 128 | −32,64 | 44,50 | −89 000 | 183 696 |
2018-04-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 6 128 | 48,45 | 10,82 | 21 640 | 66 305 |
2018-04-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 6 128 | 48,45 | 10,82 | 21 640 | 66 305 |
2018-04-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 4 128 | −32,64 | 44,30 | −88 600 | 182 870 |
2018-04-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 981 | 51 733 | −8,78 | 44,50 | −221 654 | 2 302 118 |
2018-04-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 981 | 56 714 | 9,63 | 14,69 | 73 171 | 833 129 |
2018-04-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 981 | 56 714 | 9,63 | 14,69 | 73 171 | 833 129 |
2018-04-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 981 | 51 733 | −8,78 | 44,30 | −220 658 | 2 291 772 |
2018-01-31 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 6 904 | −12,65 | ||||
2018-01-31 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 26 642 | −27,29 | ||||
2018-01-31 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 4 128 | −19,50 | 54,12 | −54 120 | 223 407 |
2018-01-31 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 5 128 | 24,22 | 10,82 | 10 820 | 55 485 |
2018-01-31 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 51 733 | −16,20 | 54,12 | −541 200 | 2 799 790 |
2018-01-31 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 61 733 | 19,33 | 14,69 | 146 900 | 906 858 |
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 722 | 3 047 | −36,11 | ||||
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −29 612 | 43 515 | −40,49 | ||||
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 3 911 | 3 911 | |||||
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 35 149 | 35 149 | |||||
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −656 | 4 128 | −13,71 | 51,76 | −33 955 | 213 665 | |
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 722 | 4 784 | 56,24 | ||||
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −15 893 | 51 733 | −23,50 | 51,76 | −822 622 | 2 677 700 | |
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 29 612 | 67 626 | 77,90 | ||||
2018-01-10 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 7 904 | −11,23 | ||||
2018-01-10 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 36 642 | −21,44 | ||||
2018-01-10 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 3 062 | −24,62 | 52,01 | −52 010 | 159 255 |
2018-01-10 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 4 062 | 32,66 | 10,82 | 10 820 | 43 951 |
2018-01-10 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 38 014 | −20,83 | 52,01 | −520 100 | 1 977 108 |
2018-01-10 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 48 014 | 26,31 | 14,69 | 146 900 | 705 326 |
2018-01-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 096 | 8 904 | −10,96 | ||||
2018-01-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −904 | 0 | −100,00 | ||||
2018-01-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −20 000 | 46 642 | −30,01 | ||||
2018-01-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 096 | 3 062 | −26,36 | 50,02 | −54 822 | 153 161 |
2018-01-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 096 | 4 158 | 35,79 | 10,82 | 11 859 | 44 990 |
2018-01-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −904 | 3 062 | −22,79 | 49,71 | −44 938 | 152 212 |
2018-01-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 904 | 3 966 | 29,52 | 7,25 | 6 554 | 28 754 |
2018-01-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 000 | 38 014 | −34,47 | 50,02 | −1 000 400 | 1 901 460 |
2018-01-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 000 | 58 014 | 52,61 | 14,69 | 293 800 | 852 226 |
2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 17 603 | 17 603 | |||||
2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 158 175 | 158 175 | |||||
2017-10-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 500 | 904 | −62,40 | ||||
2017-10-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −15 000 | 66 642 | −18,37 | ||||
2017-10-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 3 062 | −32,88 | 59,46 | −89 190 | 182 067 |
2017-10-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 500 | 4 562 | 48,99 | 7,25 | 10 875 | 33 074 |
2017-10-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 000 | 38 014 | −28,29 | 59,46 | −891 900 | 2 260 312 |
2017-10-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 53 014 | 39,46 | 14,69 | 220 350 | 778 776 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 2 404 | −29,38 | ||||
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 81 642 | −10,91 | ||||
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 3 062 | −14,04 | 54,25 | −27 125 | 166 114 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 3 562 | 16,33 | 7,25 | 3 625 | 25 824 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 3 562 | 16,33 | 7,25 | 3 625 | 25 824 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 3 062 | −14,04 | 54,20 | −27 100 | 165 960 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 38 014 | −11,62 | 54,25 | −271 250 | 2 062 260 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 43 014 | 13,15 | 14,69 | 73 450 | 631 876 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 43 014 | 13,15 | 14,69 | 73 450 | 631 876 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 38 014 | −11,62 | 54,20 | −271 000 | 2 060 359 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 500 | 3 404 | −30,59 | ||||
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −15 000 | 91 642 | −14,07 | ||||
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 3 062 | −14,04 | 52,50 | −26 250 | 160 755 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 3 562 | 16,33 | 7,25 | 3 625 | 25 824 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 3 562 | 16,33 | 7,25 | 3 625 | 25 824 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 3 562 | 16,33 | 7,25 | 3 625 | 25 824 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 3 062 | −14,04 | 52,05 | −26 025 | 159 377 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 3 062 | −14,04 | 51,45 | −25 725 | 157 540 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 38 014 | −11,62 | 52,50 | −262 500 | 1 995 735 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 43 014 | 13,15 | 14,69 | 73 450 | 631 876 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 43 014 | 13,15 | 14,69 | 73 450 | 631 876 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 43 014 | 13,15 | 14,69 | 73 450 | 631 876 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 38 014 | −11,62 | 52,05 | −260 250 | 1 978 629 |
2017-10-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 38 014 | −11,62 | 51,45 | −257 250 | 1 955 820 |
2017-07-24 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option |
M - Exercise | −1 000 | 4 904 | −16,94 | ||||
2017-07-24 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 106 642 | −8,57 | ||||
2017-07-24 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 3 062 | −24,62 | 55,35 | −55 350 | 169 482 |
2017-07-24 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 4 062 | 32,66 | 7,25 | 7 250 | 29 450 |
2017-07-24 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 38 014 | −20,83 | 55,35 | −553 500 | 2 104 075 |
2017-07-24 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 48 014 | 26,31 | 14,69 | 146 900 | 705 326 |
2017-07-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 500 | 5 904 | −20,26 | ||||
2017-07-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −15 000 | 116 642 | −11,39 | ||||
2017-07-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 3 062 | −32,88 | 52,45 | −78 675 | 160 602 |
2017-07-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 500 | 4 562 | 48,99 | 7,25 | 10 875 | 33 074 |
2017-07-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 000 | 38 014 | −28,29 | 52,45 | −786 750 | 1 993 834 |
2017-07-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 53 014 | 39,46 | 14,69 | 220 350 | 778 776 |
2017-07-13 | 3 | AKCA |
AKCEA THERAPEUTICS, INC.
No securities are beneficially owned. |
0 | ||||||||
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 500 | 7 404 | −16,85 | ||||
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 538 | 131 642 | −1,15 | ||||
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −13 462 | 0 | −100,00 | ||||
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 3 062 | −32,88 | 52,10 | −78 150 | 159 530 |
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 500 | 4 562 | 48,99 | 7,25 | 10 875 | 33 074 |
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 538 | 38 014 | −3,89 | 52,30 | −80 437 | 1 988 132 |
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 538 | 39 552 | 4,05 | 14,69 | 22 593 | 581 019 |
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −13 462 | 38 014 | −26,15 | 52,08 | −701 101 | 1 979 769 |
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 13 462 | 51 476 | 35,41 | 7,25 | 97 600 | 373 201 |
2017-04-27 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 500 | 8 904 | −14,42 | ||||
2017-04-27 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −15 000 | 13 462 | −52,70 | ||||
2017-04-27 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 3 062 | −32,88 | 47,81 | −71 715 | 146 394 |
2017-04-27 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 500 | 4 562 | 48,99 | 7,25 | 10 875 | 33 074 |
2017-04-27 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 000 | 38 014 | −28,29 | 47,81 | −717 150 | 1 817 449 |
2017-04-27 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 53 014 | 39,46 | 7,25 | 108 750 | 384 352 |
2017-04-21 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −500 | 10 404 | −4,59 | ||||
2017-04-21 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 28 462 | −14,94 | ||||
2017-04-21 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 3 062 | −14,04 | 43,25 | −21 625 | 132 432 |
2017-04-21 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 3 562 | 16,33 | 7,25 | 3 625 | 25 824 |
2017-04-21 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 38 014 | −11,62 | 43,25 | −216 250 | 1 644 106 |
2017-04-21 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 43 014 | 13,15 | 7,25 | 36 250 | 311 852 |
2017-04-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −500 | 10 904 | −4,38 | ||||
2017-04-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −500 | 10 904 | −4,38 | ||||
2017-04-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 33 462 | −23,01 | ||||
2017-04-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 3 062 | −14,04 | 41,30 | −20 650 | 126 461 |
2017-04-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 3 062 | −14,04 | 41,30 | −20 650 | 126 461 |
2017-04-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 3 562 | 16,33 | 7,25 | 3 625 | 25 824 |
2017-04-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 3 562 | 16,33 | 10,29 | 5 145 | 36 653 |
2017-04-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 38 014 | −20,83 | 41,30 | −413 000 | 1 569 978 |
2017-04-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 48 014 | 26,31 | 7,25 | 72 500 | 348 102 |
2017-04-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 500 | −66,67 | ||||
2017-04-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 43 462 | −18,70 | ||||
2017-04-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 3 062 | −24,62 | 40,07 | −40 070 | 122 694 |
2017-04-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 4 062 | 32,66 | 10,29 | 10 290 | 41 798 |
2017-04-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 38 014 | −20,83 | 40,07 | −400 700 | 1 523 221 |
2017-04-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 48 014 | 26,31 | 7,25 | 72 500 | 348 102 |
2017-03-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 100 | 1 500 | −42,31 | ||||
2017-03-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −11 000 | 53 462 | −17,06 | ||||
2017-03-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 100 | 3 062 | −26,43 | 51,05 | −56 155 | 156 315 |
2017-03-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 100 | 4 162 | 35,92 | 10,29 | 11 319 | 42 827 |
2017-03-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 000 | 38 014 | −22,44 | 51,05 | −561 550 | 1 940 615 |
2017-03-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 11 000 | 49 014 | 28,94 | 7,25 | 79 750 | 355 352 |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −131 | 3 062 | −4,10 | 46,29 | −6 064 | 141 740 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −142 | 2 859 | −4,73 | 46,29 | −6 573 | 132 346 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −139 | 2 638 | −5,01 | 46,29 | −6 434 | 122 113 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −163 | 2 423 | −6,30 | 46,29 | −7 545 | 112 163 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −4 410 | 38 014 | −10,40 | 46,29 | −204 139 | 1 759 668 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 728 | 34 291 | −9,81 | 46,29 | −172 569 | 1 587 330 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −4 236 | 31 144 | −11,97 | 46,29 | −196 080 | 1 441 625 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 008 | 27 568 | −9,84 | 46,29 | −139 237 | 1 276 095 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −334 | 999 | −25,06 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −363 | 724 | −33,39 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −354 | 354 | −50,00 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −416 | 0 | −100,00 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −8 133 | 24 397 | −25,00 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 875 | 13 750 | −33,33 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −7 812 | 7 812 | −50,00 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 547 | 0 | −100,00 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 2 692 | 2 692 | |||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 27 168 | 27 168 | |||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 334 | 3 193 | 11,68 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 363 | 3 001 | 13,76 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 354 | 2 777 | 14,61 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 416 | 2 586 | 19,17 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 8 133 | 42 424 | 23,72 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 875 | 38 019 | 22,07 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 812 | 35 380 | 28,34 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 547 | 30 576 | 22,16 | ||||
2017-01-12 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 200 | 2 600 | −31,58 | ||||
2017-01-12 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −12 000 | 64 462 | −15,69 | ||||
2017-01-12 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 200 | 2 170 | −35,61 | 49,25 | −59 100 | 106 872 |
2017-01-12 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 200 | 3 370 | 55,30 | 10,29 | 12 348 | 34 677 |
2017-01-12 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 000 | 25 029 | −32,41 | 49,25 | −591 000 | 1 232 678 |
2017-01-12 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 000 | 37 029 | 47,94 | 7,25 | 87 000 | 268 460 |
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −700 | 3 800 | −15,56 | ||||
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −7 000 | 76 462 | −8,39 | ||||
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −700 | 2 170 | −24,39 | 50,10 | −35 070 | 108 717 |
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 700 | 2 870 | 32,26 | 10,29 | 7 203 | 29 532 |
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 000 | 25 029 | −21,86 | 50,10 | −350 700 | 1 253 953 |
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 000 | 32 029 | 27,97 | 7,25 | 50 750 | 232 210 |
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 4 500 | −18,18 | ||||
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 83 462 | −10,70 | ||||
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 16 157 | 16 157 | |||||
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 163 013 | 163 013 | |||||
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 2 170 | −18,73 | 48,80 | −24 400 | 105 896 |
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 2 670 | 23,04 | 10,29 | 5 145 | 27 474 |
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 2 670 | 23,04 | 10,29 | 5 145 | 27 474 |
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 2 170 | −18,73 | 47,30 | −23 650 | 102 641 |
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 25 029 | −16,65 | 48,80 | −244 000 | 1 221 415 |
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 30 029 | 19,98 | 7,25 | 36 250 | 217 710 |
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 30 029 | 19,98 | 7,25 | 36 250 | 217 710 |
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 25 029 | −16,65 | 47,30 | −236 500 | 1 183 872 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 5 500 | −15,38 | ||||
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 93 462 | −9,67 | ||||
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 2 170 | −31,55 | 42,22 | −42 220 | 91 617 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 3 170 | 46,08 | 10,29 | 10 290 | 32 619 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 25 029 | −28,55 | 40,23 | −402 300 | 1 006 917 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 35 029 | 39,95 | 7,25 | 72 500 | 253 960 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 000 | 6 500 | −23,53 | ||||
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −3 741 | 103 462 | −3,49 | ||||
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −16 259 | 0 | −100,00 | ||||
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 2 170 | −31,55 | 37,25 | −37 250 | 80 832 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 3 170 | 46,08 | 10,29 | 10 290 | 32 619 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 3 170 | 46,08 | 10,29 | 10 290 | 32 619 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 2 170 | −31,55 | 35,10 | −35 100 | 76 167 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 741 | 25 029 | −13,00 | 37,50 | −140 288 | 938 588 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 741 | 28 770 | 14,95 | 7,25 | 27 122 | 208 582 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 259 | 25 029 | −20,00 | 37,10 | −232 209 | 928 576 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 259 | 31 288 | 25,01 | 10,29 | 64 405 | 321 954 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 25 029 | −28,55 | 35,55 | −355 500 | 889 781 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 35 029 | 39,95 | 10,29 | 102 900 | 360 448 |
2016-10-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 8 500 | −10,53 | ||||
2016-10-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 16 259 | −38,08 | ||||
2016-10-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 2 170 | −31,55 | 36,61 | −36 610 | 79 444 |
2016-10-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 3 170 | 46,08 | 10,29 | 10 290 | 32 619 |
2016-10-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 25 029 | −28,55 | 36,61 | −366 100 | 916 312 |
2016-10-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 35 029 | 39,95 | 10,29 | 102 900 | 360 448 |
2016-09-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 000 | 9 500 | −17,39 | ||||
2016-09-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Empoyee Stock Option (right to buy) |
M - Exercise | −20 000 | 26 259 | −43,23 | ||||
2016-09-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 2 170 | −47,96 | 36,05 | −72 100 | 78 228 |
2016-09-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 4 170 | 92,17 | 10,29 | 20 580 | 42 909 |
2016-09-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 000 | 25 029 | −44,42 | 36,02 | −720 400 | 901 545 |
2016-09-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 000 | 45 029 | 79,91 | 10,29 | 205 800 | 463 348 |
2016-09-23 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 000 | 11 500 | −14,81 | ||||
2016-09-23 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −20 000 | 46 259 | −30,18 | ||||
2016-09-23 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 2 170 | −47,96 | 35,50 | −71 000 | 77 035 |
2016-09-23 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 4 170 | 92,17 | 10,29 | 20 580 | 42 909 |
2016-09-23 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 000 | 25 029 | −44,42 | 35,50 | −710 000 | 888 530 |
2016-09-23 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 000 | 45 029 | 79,91 | 10,29 | 205 800 | 463 348 |
2016-04-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 13 500 | −6,90 | ||||
2016-04-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 66 259 | −13,11 | ||||
2016-04-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 2 170 | −18,73 | 46,30 | −23 150 | 100 471 |
2016-04-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 2 670 | 23,04 | 10,29 | 5 145 | 27 474 |
2016-04-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 2 670 | 23,04 | 10,29 | 5 145 | 27 474 |
2016-04-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 2 170 | −18,73 | 45,95 | −22 975 | 99 712 |
2016-04-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 25 029 | −16,65 | 46,30 | −231 500 | 1 158 843 |
2016-04-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 30 029 | 19,98 | 10,29 | 51 450 | 308 998 |
2016-04-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 30 029 | 19,98 | 10,29 | 51 450 | 308 998 |
2016-04-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 25 029 | −16,65 | 45,95 | −229 750 | 1 150 083 |
2016-04-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −500 | 14 500 | −3,33 | ||||
2016-04-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −500 | 14 500 | −3,33 | ||||
2016-04-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 76 259 | −11,59 | ||||
2016-04-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 2 170 | −18,73 | 40,75 | −20 375 | 88 428 |
2016-04-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 2 670 | 23,04 | 10,29 | 5 145 | 27 474 |
2016-04-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 2 170 | −18,73 | 40,72 | −20 360 | 88 362 |
2016-04-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 2 670 | 23,04 | 9,22 | 4 610 | 24 617 |
2016-04-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 25 029 | −16,65 | 40,72 | −203 600 | 1 019 181 |
2016-04-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 30 029 | 19,98 | 10,29 | 51 450 | 308 998 |
2016-04-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 30 029 | 19,98 | 10,29 | 51 450 | 308 998 |
2016-04-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 25 029 | −16,65 | 40,75 | −203 750 | 1 019 932 |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −145 | 2 170 | −6,26 | 41,46 | −6 012 | 89 968 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −141 | 1 952 | −6,74 | 41,46 | −5 846 | 80 936 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −166 | 1 739 | −8,71 | 41,46 | −6 883 | 72 103 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −124 | 1 489 | −7,69 | 41,46 | −5 141 | 61 735 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 798 | 25 029 | −13,18 | 41,47 | −157 486 | 1 037 840 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −4 317 | 21 952 | −16,43 | 41,46 | −178 962 | 910 022 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 065 | 18 456 | −14,24 | 41,46 | −127 069 | 765 153 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 645 | 15 974 | −9,34 | 41,46 | −68 199 | 662 253 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −363 | 1 087 | −25,03 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −354 | 708 | −33,33 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −416 | 416 | −50,00 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −316 | 0 | −100,00 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 875 | 20 625 | −25,00 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −7 813 | 15 624 | −33,34 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 547 | 5 547 | −50,00 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −2 977 | 0 | −100,00 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 1 333 | 1 333 | |||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 32 530 | 32 530 | |||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 363 | 2 315 | 18,60 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 354 | 2 093 | 20,36 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 416 | 1 905 | 27,94 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 316 | 1 613 | 24,36 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 875 | 28 827 | 31,32 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 813 | 26 269 | 42,33 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 547 | 21 521 | 34,73 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 977 | 17 619 | 20,33 | ||||
2016-01-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −500 | 500 | −50,00 | ||||
2016-01-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 86 259 | −5,48 | ||||
2016-01-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 1 297 | −27,82 | 62,10 | −31 050 | 80 544 |
2016-01-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 1 797 | 38,55 | 9,22 | 4 610 | 16 568 |
2016-01-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 14 642 | −25,46 | 62,10 | −310 500 | 909 268 |
2016-01-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 19 642 | 34,15 | 10,29 | 51 450 | 202 116 |
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 1 000 | −50,00 | ||||
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 91 259 | −9,88 | ||||
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 8 000 | 8 000 | |||||
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 195 182 | 195 182 | |||||
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 1 297 | −43,54 | 61,05 | −61 050 | 79 182 |
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 2 297 | 77,10 | 9,22 | 9 220 | 21 178 |
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 14 642 | −40,58 | 61,05 | −610 500 | 893 894 |
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 24 642 | 68,30 | 10,29 | 102 900 | 253 566 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 2 000 | −55,56 | ||||
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −20 837 | 101 259 | −17,07 | ||||
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −4 163 | 0 | −100,00 | ||||
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 1 297 | −27,82 | 45,30 | −22 650 | 58 754 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 1 797 | 38,55 | 9,22 | 4 610 | 16 568 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 1 297 | −60,66 | 44,18 | −88 350 | 57 295 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 3 297 | 154,20 | 9,22 | 18 440 | 30 398 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 14 642 | −25,46 | 45,30 | −226 500 | 663 283 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 19 642 | 34,15 | 10,29 | 51 450 | 202 116 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 837 | 14 642 | −51,96 | 44,18 | −699 599 | 646 810 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 837 | 30 479 | 108,16 | 10,29 | 162 963 | 313 629 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 163 | 14 642 | −22,14 | 43,90 | −182 756 | 642 784 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 163 | 18 805 | 28,43 | 11,27 | 46 917 | 211 932 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −500 | 4 500 | −10,00 | ||||
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 0 | −100,00 | ||||
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −15 000 | 4 163 | −78,28 | ||||
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 1 297 | −27,82 | 43,00 | −21 500 | 55 771 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 500 | 1 797 | 38,55 | 9,22 | 4 610 | 16 568 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 1 297 | −43,54 | 43,00 | −43 000 | 55 771 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 2 297 | 77,10 | 11,27 | 11 270 | 25 887 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 000 | 14 642 | −50,60 | 43,00 | −645 000 | 629 606 |
2015-10-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 29 642 | 102,45 | 11,27 | 169 050 | 334 065 |
2015-07-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 175 | 5 000 | −19,03 | ||||
2015-07-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 19 163 | −20,69 | ||||
2015-07-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 175 | 1 297 | −47,53 | 57,01 | −66 983 | 73 938 |
2015-07-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 175 | 2 472 | 90,59 | 9,22 | 10 834 | 22 792 |
2015-07-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 14 642 | −25,46 | 57,01 | −285 035 | 834 696 |
2015-07-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 19 642 | 34,15 | 11,27 | 56 350 | 221 365 |
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 175 | 6 175 | −15,99 | ||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 24 163 | −17,15 | ||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 175 | 1 297 | −47,53 | 57,56 | −67 634 | 74 657 |
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 175 | 2 472 | 90,59 | 9,22 | 10 834 | 22 792 |
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 14 642 | −25,46 | 57,56 | −287 805 | 842 808 |
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 19 642 | 34,15 | 11,27 | 56 350 | 221 365 |
2015-04-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 034 | 7 350 | −21,68 | ||||
2015-04-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −20 343 | 29 163 | −41,09 | ||||
2015-04-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 034 | 1 297 | −61,06 | 63,07 | −128 286 | 81 803 |
2015-04-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 034 | 3 331 | 156,82 | 9,22 | 18 753 | 30 712 |
2015-04-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 343 | 14 642 | −58,15 | 63,07 | −1 283 053 | 923 486 |
2015-04-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 343 | 34 985 | 138,94 | 11,27 | 229 266 | 394 281 |
2015-04-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 966 | 9 384 | −17,32 | ||||
2015-04-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −19 657 | 49 506 | −28,42 | ||||
2015-04-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 966 | 1 297 | −60,25 | 61,93 | −121 759 | 80 326 |
2015-04-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 966 | 3 263 | 151,58 | 9,22 | 18 127 | 30 085 |
2015-04-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −19 657 | 14 642 | −57,31 | 61,93 | −1 217 399 | 906 810 |
2015-04-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 19 657 | 34 299 | 134,25 | 11,27 | 221 534 | 386 550 |
2015-01-29 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 11 350 | −8,10 | ||||
2015-01-29 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 69 163 | −12,63 | ||||
2015-01-29 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 1 297 | −43,54 | 72,93 | −72 926 | 94 585 |
2015-01-29 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 2 297 | 77,10 | 9,22 | 9 220 | 21 178 |
2015-01-29 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 14 642 | −40,58 | 72,93 | −729 260 | 1 067 782 |
2015-01-29 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 24 642 | 68,30 | 11,27 | 112 700 | 277 715 |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −136 | 1 297 | −9,49 | 67,96 | −9 243 | 88 149 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −160 | 1 079 | −12,91 | 67,96 | −10 874 | 73 333 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −121 | 822 | −12,83 | 67,96 | −8 224 | 55 866 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −4 130 | 14 642 | −22,00 | 67,96 | −280 693 | 995 136 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 933 | 10 959 | −21,11 | 67,96 | −199 338 | 744 817 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 574 | 8 344 | −15,87 | 67,96 | −106 975 | 567 092 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −354 | 1 062 | −25,00 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −417 | 832 | −33,39 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −316 | 316 | −50,00 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −7 813 | 23 437 | −25,00 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 548 | 11 094 | −33,34 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −2 977 | 2 977 | −50,00 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 1 450 | 1 450 | |||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 27 500 | 27 500 | |||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 354 | 1 433 | 32,81 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 417 | 1 239 | 50,73 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 316 | 943 | 50,40 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 813 | 18 772 | 71,29 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 548 | 13 892 | 66,49 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 977 | 9 918 | 42,89 | ||||
2015-01-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 12 350 | −7,49 | ||||
2015-01-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 79 163 | −11,22 | ||||
2015-01-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 627 | −61,46 | 73,57 | −73 570 | 46 128 |
2015-01-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 1 627 | 159,49 | 9,22 | 9 220 | 15 001 |
2015-01-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 6 941 | −59,03 | 73,57 | −735 700 | 510 649 |
2015-01-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 16 941 | 144,07 | 11,27 | 112 700 | 190 925 |
2015-01-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 13 350 | −6,97 | ||||
2015-01-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 89 163 | −10,08 | ||||
2015-01-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 627 | −61,46 | 68,05 | −68 048 | 42 666 |
2015-01-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 1 627 | 159,49 | 9,22 | 9 220 | 15 001 |
2015-01-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 6 941 | −59,03 | 68,05 | −680 480 | 472 321 |
2015-01-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 16 941 | 144,07 | 11,27 | 112 700 | 190 925 |
2015-01-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 14 350 | −6,51 | ||||
2015-01-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 99 163 | −9,16 | ||||
2015-01-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 627 | −61,46 | 66,04 | −66 038 | 41 406 |
2015-01-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 1 627 | 159,49 | 9,22 | 9 220 | 15 001 |
2015-01-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 6 941 | −59,03 | 66,04 | −660 380 | 458 370 |
2015-01-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 16 941 | 144,07 | 11,27 | 112 700 | 190 925 |
2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 8 700 | 8 700 | |||||
2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 165 000 | 165 000 | |||||
2014-10-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 600 | 15 350 | −9,44 | ||||
2014-10-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 109 163 | −8,39 | ||||
2014-10-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −3 000 | 0 | −100,00 | ||||
2014-10-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 600 | 627 | −71,85 | 42,22 | −67 552 | 26 472 |
2014-10-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 600 | 2 227 | 255,18 | 9,22 | 14 752 | 20 533 |
2014-10-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 6 941 | −59,03 | 42,22 | −422 200 | 293 049 |
2014-10-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 16 941 | 144,07 | 11,27 | 112 700 | 190 925 |
2014-10-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 6 941 | −30,18 | 42,22 | −126 660 | 293 049 |
2014-10-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 9 941 | 43,22 | 14,47 | 43 410 | 143 846 |
2014-10-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 16 950 | −5,57 | ||||
2014-10-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −13 000 | 3 000 | −81,25 | ||||
2014-10-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 627 | −61,46 | 39,49 | −39 487 | 24 758 |
2014-10-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 1 627 | 159,49 | 9,22 | 9 220 | 15 001 |
2014-10-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −13 000 | 6 941 | −65,19 | 39,49 | −513 331 | 274 079 |
2014-10-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 13 000 | 19 941 | 187,29 | 14,47 | 188 110 | 288 546 |
2014-10-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −800 | 17 950 | −4,27 | ||||
2014-10-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 200 | 1 000 | −54,55 | ||||
2014-10-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −20 000 | 16 000 | −55,56 | ||||
2014-10-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −800 | 627 | −56,06 | 37,91 | −30 329 | 23 770 |
2014-10-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 800 | 1 427 | 127,59 | 9,22 | 7 376 | 13 157 |
2014-10-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 200 | 627 | −65,68 | 37,91 | −45 493 | 23 770 |
2014-10-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 200 | 1 827 | 191,39 | 11,27 | 13 524 | 20 590 |
2014-10-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 000 | 6 941 | −74,24 | 37,91 | −758 220 | 263 140 |
2014-10-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 000 | 26 941 | 288,14 | 14,47 | 289 400 | 389 836 |
2014-08-15 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 600 | 2 200 | −42,11 | ||||
2014-08-15 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −15 500 | 36 000 | −30,10 | ||||
2014-08-15 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 600 | 627 | −71,85 | 35,45 | −56 726 | 22 230 |
2014-08-15 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 600 | 2 227 | 255,18 | 11,27 | 18 032 | 25 098 |
2014-08-15 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 500 | 6 941 | −69,07 | 35,45 | −549 537 | 246 086 |
2014-08-15 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 500 | 22 441 | 223,31 | 14,47 | 224 285 | 324 721 |
2014-08-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 3 800 | −20,83 | ||||
2014-08-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −15 000 | 51 500 | −22,56 | ||||
2014-08-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 627 | −61,46 | 30,52 | −30 525 | 19 139 |
2014-08-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 1 627 | 159,49 | 11,27 | 11 270 | 18 336 |
2014-08-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 000 | 6 941 | −68,37 | 30,52 | −457 875 | 211 874 |
2014-08-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 21 941 | 216,11 | 14,47 | 217 050 | 317 486 |
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 800 | 4 800 | −27,27 | ||||
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −200 | 0 | −100,00 | ||||
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 15 500 | 66 500 | 30,39 | ||||
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 800 | 627 | −74,17 | 35,55 | −63 990 | 22 290 |
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 800 | 2 427 | 287,08 | 11,27 | 20 286 | 27 352 |
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 627 | −24,18 | 35,55 | −7 110 | 22 290 |
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 200 | 827 | 31,90 | 14,47 | 2 894 | 11 967 |
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 500 | 6 941 | −69,07 | 35,58 | −551 459 | 246 947 |
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 500 | 22 441 | 223,31 | 14,47 | 224 285 | 324 721 |
2014-06-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −11 000 | 82 000 | −11,83 | ||||
2014-06-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 000 | 6 941 | −61,31 | 35,10 | −386 111 | 243 636 |
2014-06-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 11 000 | 17 941 | 158,48 | 14,47 | 159 170 | 259 606 |
2014-06-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 200 | −83,33 | ||||
2014-06-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 93 000 | −9,71 | ||||
2014-06-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 627 | −61,46 | 33,46 | −33 455 | 20 976 |
2014-06-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 1 627 | 159,49 | 14,47 | 14 470 | 23 543 |
2014-06-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 6 941 | −59,03 | 33,46 | −334 550 | 232 211 |
2014-06-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 16 941 | 144,07 | 14,47 | 144 700 | 245 136 |
2014-04-04 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 800 | 1 200 | −60,00 | ||||
2014-04-04 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −7 000 | 103 000 | −6,36 | ||||
2014-04-04 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 800 | 627 | −74,17 | 43,65 | −78 566 | 27 367 |
2014-04-04 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 800 | 2 427 | 287,08 | 14,47 | 26 046 | 35 119 |
2014-04-04 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 000 | 6 941 | −50,21 | 43,65 | −305 536 | 302 961 |
2014-04-04 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 000 | 13 941 | 100,85 | 14,47 | 101 290 | 201 726 |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −121 | 627 | −16,18 | 47,08 | −5 697 | 29 520 | |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −160 | 431 | −27,07 | 47,08 | −7 533 | 20 291 | |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 134 | 6 941 | −14,04 | 47,08 | −53 390 | 326 790 | |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 112 | 5 097 | −29,30 | 47,08 | −99 435 | 239 973 | |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted StockUnits |
M - Exercise | −317 | 632 | −33,40 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −417 | 1 249 | −25,03 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −2 978 | 5 954 | −33,34 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 548 | 16 642 | −25,00 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 1 416 | 1 416 | |||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 31 250 | 31 250 | |||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 317 | 748 | 73,55 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 417 | 591 | 239,66 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 978 | 8 075 | 58,43 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 548 | 7 209 | 334,02 | ||||
2014-01-10 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 500 | 3 000 | −33,33 | ||||
2014-01-10 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −11 000 | 110 000 | −9,09 | ||||
2014-01-10 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 174 | −89,61 | 40,05 | −60 078 | 6 969 |
2014-01-10 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 500 | 1 674 | 862,07 | 14,47 | 21 705 | 24 223 |
2014-01-10 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 000 | 1 661 | −86,88 | 40,05 | −440 572 | 66 526 |
2014-01-10 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 11 000 | 12 661 | 662,25 | 14,47 | 159 170 | 183 205 |
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 8 500 | 8 500 | |||||
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 187 500 | 187 500 | |||||
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 174 | −93,49 | 39,25 | −98 132 | 6 830 |
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 500 | 2 674 | 1 436,78 | 14,47 | 36 175 | 38 693 |
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 000 | 1 661 | −70,66 | 40,00 | −160 000 | 66 440 |
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 5 661 | 240,82 | 14,47 | 57 880 | 81 915 |
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −25 000 | 1 661 | −93,77 | 39,25 | −981 325 | 65 199 |
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 25 000 | 26 661 | 1 505,12 | 14,47 | 361 750 | 385 785 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −8 740 | 0 | −100,00 | ||||
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 740 | 1 661 | −84,03 | 35,90 | −313 749 | 59 627 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 740 | 10 401 | 526,19 | 11,12 | 97 189 | 115 659 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −50 000 | 8 740 | −85,12 | ||||
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 1 661 | −94,75 | 35,02 | −1 050 600 | 58 168 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 31 661 | 1 806,14 | 11,12 | 333 600 | 352 070 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 000 | 1 661 | −92,33 | 35,12 | −702 480 | 58 341 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 000 | 21 661 | 1 204,09 | 11,12 | 222 400 | 240 870 |
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 000 | 725 391 | −2,68 | 31,18 | −623 620 | 22 618 417 |
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 745 391 | −3,87 | 31,65 | −949 440 | 23 590 134 |
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −26 615 | 58 740 | −31,18 | ||||
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −26 615 | 1 661 | −94,13 | 30,42 | −809 495 | 50 519 |
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 26 615 | 28 276 | 1 602,35 | 11,12 | 295 959 | 314 429 |
2013-07-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −11 500 | 85 355 | −11,87 | ||||
2013-07-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 500 | 1 661 | −87,38 | 30,00 | −345 000 | 49 830 |
2013-07-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 11 500 | 13 161 | 692,35 | 11,12 | 127 880 | 146 350 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 885 | 96 855 | −1,91 | ||||
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −18 115 | 0 | −100,00 | ||||
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 885 | 1 661 | −53,16 | 31,02 | −58 473 | 51 524 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 885 | 3 546 | 113,49 | 11,12 | 20 961 | 39 432 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 115 | 1 661 | −83,01 | 31,02 | −251 727 | 51 524 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 115 | 9 776 | 488,56 | 15,38 | 124 809 | 150 355 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 1 661 | −85,76 | 30,52 | −305 250 | 50 702 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 11 661 | 602,05 | 15,38 | 153 800 | 179 346 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −22 200 | 18 115 | −55,07 | ||||
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 1 661 | −85,76 | 30,18 | −301 850 | 50 137 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 11 661 | 602,05 | 15,38 | 153 800 | 179 346 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 11 661 | 602,05 | 15,38 | 153 800 | 179 346 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 1 661 | −85,76 | 30,87 | −308 720 | 51 278 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 200 | 1 661 | −56,98 | 31,40 | −69 080 | 52 155 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 200 | 3 861 | 132,45 | 15,38 | 33 836 | 59 382 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −20 000 | 98 740 | −16,84 | ||||
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 1 661 | −85,76 | 30,02 | −300 220 | 49 867 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 11 661 | 602,05 | 11,12 | 111 200 | 129 670 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 11 661 | 602,05 | 11,12 | 111 200 | 129 670 |
2013-07-22 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 1 661 | −85,76 | 30,20 | −302 000 | 50 162 |
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Emloyee Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −8 300 | 0 | −100,00 | ||||
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 174 | −96,64 | 31,96 | −159 800 | 5 561 |
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 174 | 2 873,56 | 9,92 | 49 600 | 51 326 |
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −44 | 174 | −20,18 | 31,96 | −1 406 | 5 561 |
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 44 | 218 | 25,29 | 15,38 | 677 | 3 353 |
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 256 | 174 | −97,94 | 31,22 | −257 752 | 5 432 |
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 256 | 8 430 | 4 744,83 | 15,38 | 126 977 | 129 653 |
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −6 000 | 118 740 | −4,81 | ||||
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 000 | 1 661 | −78,32 | 33,31 | −199 842 | 55 323 |
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 000 | 7 661 | 361,23 | 11,12 | 66 720 | 85 190 |
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 124 740 | −19,39 | ||||
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 1 661 | −85,76 | 33,56 | −335 650 | 55 751 |
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 11 661 | 602,05 | 11,12 | 111 200 | 129 670 |
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 11 661 | 602,05 | 11,12 | 111 200 | 129 670 |
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 1 661 | −85,76 | 33,80 | −338 050 | 56 150 |
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 1 661 | −85,76 | 34,05 | −340 480 | 56 554 |
2013-07-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 11 661 | 602,05 | 11,12 | 111 200 | 129 670 |
2013-07-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −24 000 | 36 000 | −40,00 | ||||
2013-07-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −6 000 | 40 315 | −12,95 | ||||
2013-07-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 000 | 1 661 | −87,84 | 33,50 | −402 010 | 55 645 |
2013-07-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 000 | 13 661 | 722,46 | 11,12 | 133 440 | 151 910 |
2013-07-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 000 | 13 661 | 722,46 | 11,12 | 133 440 | 151 910 |
2013-07-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 000 | 1 661 | −87,84 | 33,08 | −397 008 | 54 953 |
2013-07-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 000 | 1 661 | −78,32 | 32,83 | −196 980 | 54 531 |
2013-07-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 000 | 7 661 | 361,23 | 15,38 | 92 280 | 117 826 |
2013-07-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 46 315 | −39,31 | ||||
2013-07-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 1 661 | −94,75 | 32,00 | −960 090 | 53 157 |
2013-07-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 311 661 | 10,65 | 15,38 | 461 400 | 4 793 346 |
2013-07-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 76 315 | −28,22 | ||||
2013-07-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 1 661 | −94,75 | 30,05 | −901 440 | 49 910 |
2013-07-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 31 661 | 1 806,14 | 15,38 | 461 400 | 486 946 |
2013-07-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 106 315 | −22,01 | ||||
2013-07-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 1 661 | −94,75 | 30,04 | −901 290 | 49 901 |
2013-07-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 31 661 | 1 806,14 | 15,38 | 461 400 | 486 946 |
2013-07-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 136 315 | −18,04 | ||||
2013-07-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −24 992 | 1 661 | −93,77 | 30,09 | −752 009 | 49 979 |
2013-07-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | 24 992 | 26 653 | 1 504,64 | 15,38 | 384 377 | 409 923 |
2013-07-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 008 | 1 661 | −75,09 | 30,03 | −150 370 | 49 873 |
2013-07-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 008 | 6 669 | 301,51 | 15,38 | 77 023 | 102 569 |
2013-07-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −24 180 | 166 315 | −12,69 | ||||
2013-07-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −24 180 | 1 661 | −93,57 | 30,02 | −725 763 | 49 855 |
2013-07-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 24 180 | 25 841 | 1 455,75 | 15,38 | 371 888 | 397 435 |
2013-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 775 391 | −1,27 | 28,17 | −281 700 | 21 842 764 |
2013-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 958 | 0 | −100,00 | ||||
2013-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −4 725 | 0 | −100,00 | ||||
2013-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2013-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 958 | 174 | −97,16 | 27,31 | −162 713 | 4 752 |
2013-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 958 | 6 132 | 3 424,14 | 11,12 | 66 253 | 68 188 |
2013-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 725 | 174 | −96,45 | 27,31 | −129 040 | 4 752 |
2013-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 725 | 4 899 | 2 715,52 | 6,81 | 32 177 | 33 362 |
2013-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 1 661 | −85,76 | 27,07 | −270 700 | 44 963 |
2013-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 11 661 | 602,05 | 6,81 | 68 100 | 79 411 |
2013-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −20 000 | 10 000 | −66,67 | ||||
2013-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 1 661 | −85,76 | 27,40 | −274 000 | 45 511 |
2013-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 11 661 | 602,05 | 6,81 | 68 100 | 79 411 |
2013-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 11 661 | 602,05 | 6,81 | 68 100 | 79 411 |
2013-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 1 661 | −85,76 | 28,30 | −283 000 | 47 006 |
2013-06-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −20 000 | 30 000 | −40,00 | ||||
2013-06-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 785 391 | −1,26 | 26,70 | −267 000 | 20 969 940 |
2013-06-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 000 | 1 661 | −92,33 | 27,10 | −542 020 | 45 015 |
2013-06-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 000 | 21 661 | 1 204,09 | 6,81 | 136 200 | 147 511 |
2013-06-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 50 000 | −37,50 | ||||
2013-06-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −19 565 | 1 661 | −92,17 | 27,86 | −545 179 | 46 284 |
2013-06-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 19 565 | 21 226 | 1 177,90 | 6,81 | 133 238 | 144 549 |
2013-06-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 435 | 1 661 | −86,27 | 28,32 | −295 519 | 47 040 |
2013-06-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 435 | 12 096 | 628,24 | 6,81 | 71 062 | 82 374 |
2013-06-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −13 730 | 795 391 | −1,70 | 25,22 | −346 271 | 20 059 761 |
2013-06-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −16 270 | 809 121 | −1,97 | 25,16 | −409 353 | 20 357 484 |
2013-04-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 825 391 | −1,20 | 22,12 | −221 200 | 18 257 649 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −30 000 | 835 391 | −3,47 | 22,10 | −662 901 | 18 459 384 | |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 865 391 | −1,14 | 20,99 | −209 900 | 18 164 557 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 000 | 1 661 | −92,33 | 20,99 | −419 800 | 34 864 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 000 | 21 661 | 1 204,09 | 7,26 | 145 200 | 157 259 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 20 000 | −60,00 | ||||
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 1 661 | −94,75 | 20,01 | −600 180 | 33 230 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 31 661 | 1 806,14 | 7,26 | 217 800 | 229 859 |
2013-02-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 133 180 | 133 180 | |||||
2013-02-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 22 190 | 22 190 | |||||
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −143 | 174 | −45,11 | 14,00 | −2 002 | 2 436 | |
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 317 | 1 661 | −44,22 | 14,00 | −18 438 | 23 254 | |
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 1 666 | 1 666 | |||||
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −317 | 949 | −25,04 | ||||
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −2 978 | 8 932 | −25,00 | ||||
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 317 | 317 | |||||
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 978 | 2 978 | |||||
2013-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2012-11-07 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Stock Option (Right to Buy) |
A - Award | 25 000 | 25 000 | |||||
2012-10-11 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Series A Preferred Stock |
C - Conversion | −6 299 500 | 0 | −100,00 | ||||
2012-10-11 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
P - Purchase | 750 000 | 7 049 500 | 11,91 | 4,00 | 3 000 000 | 28 198 000 | |
2012-10-11 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
C - Conversion | 6 299 500 | 6 299 500 | |||||
2012-09-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −29 462 | 0 | −100,00 | ||||
2012-09-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −29 462 | 0 | −100,00 | 14,06 | −414 236 | |
2012-09-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 29 462 | 29 462 | 6,84 | 201 520 | 201 520 | |
2012-09-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −20 538 | 29 462 | −41,08 | ||||
2012-09-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −9 462 | 0 | −100,00 | ||||
2012-09-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | 20 538 | 0 | −100,00 | 15,01 | 308 234 | |
2012-09-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 538 | 20 538 | 6,84 | 140 480 | 140 480 | |
2012-09-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 462 | 0 | −100,00 | 15,01 | −142 006 | |
2012-09-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 9 462 | 9 462 | 5,25 | 49 676 | 49 676 | |
2012-09-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 9 462 | −76,02 | ||||
2012-09-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 0 | −100,00 | 14,82 | −444 450 | |
2012-09-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 30 000 | 5,25 | 157 500 | 157 500 | |
2012-09-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −27 074 | 39 462 | −40,69 | ||||
2012-09-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −27 074 | 0 | −100,00 | 14,55 | −393 927 | |
2012-09-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 27 074 | 27 074 | 5,25 | 142 138 | 142 138 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −6 000 | 0 | −100,00 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −4 687 | 0 | −100,00 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 925 | 0 | −100,00 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −17 388 | 66 536 | −20,72 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 000 | 0 | −100,00 | 15,00 | −90 012 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 000 | 6 000 | 5,25 | 31 500 | 31 500 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −306 | 0 | −100,00 | 15,00 | −4 591 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 306 | 306 | 5,25 | 1 606 | 1 606 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 381 | 0 | −100,00 | 15,04 | −65 868 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 381 | 4 381 | 5,25 | 23 000 | 23 000 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 925 | 0 | −100,00 | 15,04 | −28 942 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 925 | 1 925 | 6,84 | 13 167 | 13 167 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 694 | 0 | −100,00 | 15,04 | −130 714 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 694 | 8 694 | 5,25 | 45 644 | 45 644 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 694 | 0 | −100,00 | 15,00 | −130 427 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 694 | 8 694 | 5,25 | 45 644 | 45 644 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −15 000 | 83 924 | −15,16 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 14,82 | −222 345 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 5,25 | 78 750 | 78 750 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 98 924 | −23,27 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 0 | −100,00 | 14,11 | −423 255 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 30 000 | 5,25 | 157 500 | 157 500 | |
2012-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 1 266 | 1 266 | |||||
2012-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 11 910 | 11 910 | |||||
2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 11 404 | 11 404 | |||||
2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 107 203 | 107 203 | |||||
2010-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 6 600 | 6 600 | |||||
2010-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 119 163 | 119 163 | |||||
2004-12-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 7 051 | −41,49 | ||||
2004-12-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 922 241 | −0,54 | 4,90 | −24 479 | 4 515 107 |
2004-12-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 000 | 927 241 | 0,54 | 4,00 | 20 000 | 3 708 964 | |
2004-12-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −4 000 | 12 051 | −24,92 | ||||
2004-12-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 000 | 922 241 | −0,43 | 4,70 | −18 820 | 4 339 144 |
2004-12-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 000 | 926 241 | 0,43 | 4,00 | 16 000 | 3 704 964 | |
2004-12-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 549 | 16 051 | −8,80 | ||||
2004-12-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 549 | 922 241 | −0,17 | 4,62 | −7 153 | 4 258 817 |
2004-12-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 549 | 923 790 | 0,17 | 4,00 | 6 196 | 3 695 160 |